(INVE-A) Investor ser. - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015811955

INVE-A: Buyouts, Growth Capital, Healthcare, Financial Services, IT, Fintech

Investor AB ser. A (ST:INVE-A) is a Swedish private equity firm with a strategic focus on mature, middle-market buyouts and growth capital investments. The firm specializes in core investments across healthcare, financial services, IT, and fintech sectors, often taking leading minority positions in listed companies. Additionally, it operates investments targeting medium to large-sized companies in Northern Europe, with a broad geographic reach spanning North Africa, Sub-Saharan Africa, Asia-Pacific, and various regions in Europe and the Americas. The firm typically invests between SEK 20 million ($1.83 million) and SEK 200 million ($18.28 million), with a preference for majority or minority stakes in both listed and unlisted companies. It seeks controlling interests or significant influence in its portfolio companies for operating investments, while financial investments focus on minority stakes with shorter horizons. The firm aims to exit private equity investments within three to seven years and actively participates in portfolio company governance through board memberships. Founded in 1916 and headquartered in Stockholm, Sweden, Investor AB is a seasoned player in the private equity landscape.

Over the next three months, the stock is expected to face headwinds due to its technical position. The SMA 20 (286.45) and SMA 50 (303.22) are above the current price of 278.10, while the SMA 200 (300.54) suggests a bearish trend. The ATR of 8.60 indicates moderate volatility, which could lead to price fluctuations. On the fundamental side, the low P/E ratio of 7.43 and P/B ratio of 1.03 suggest undervaluation, potentially attracting value investors. The RoE of 13.83% reflects solid profitability. The 3-month forecast indicates that while short-term technical weakness may pressure the stock, its strong financials could stabilize it, making it a resilient investment despite near-term challenges.

Additional Sources for INVE-A Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

INVE-A Stock Overview

Market Cap in USD 88,070m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Environmental & Facilities Services
IPO / Inception

INVE-A Stock Ratings

Growth Rating 83.4
Fundamental 32.1
Dividend Rating 17.7
Rel. Strength -0.22
Analysts -
Fair Price Momentum 287.03 SEK
Fair Price DCF 335.68 SEK

INVE-A Dividends

Dividend Yield 12m 1.66%
Yield on Cost 5y 4.97%
Annual Growth 5y -21.64%
Payout Consistency 90.3%

INVE-A Growth Ratios

Growth Correlation 3m -73%
Growth Correlation 12m 54.5%
Growth Correlation 5y 91%
CAGR 5y 23.85%
CAGR/Max DD 5y 0.82
Sharpe Ratio 12m 1.06
Alpha -0.53
Beta 0.716
Volatility 37.46%
Current Volume 302.3k
Average Volume 20d 389.1k
What is the price of INVE-A stocks?
As of April 25, 2025, the stock is trading at SEK 282.60 with a total of 302,271 shares traded.
Over the past week, the price has changed by +1.62%, over one month by -8.66%, over three months by -10.11% and over the past year by +7.02%.
Is Investor ser. a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Investor ser. is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.11 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INVE-A as of April 2025 is 287.03. This means that INVE-A is currently overvalued and has a potential downside of 1.57%.
Is INVE-A a buy, sell or hold?
Investor ser. has no consensus analysts rating.
What are the forecast for INVE-A stock price target?
According to ValueRays Forecast Model, INVE-A Investor ser. will be worth about 318.7 in April 2026. The stock is currently trading at 282.60. This means that the stock has a potential upside of +12.77%.
Issuer Forecast Upside
Wallstreet Target Price 296.5 4.9%
Analysts Target Price - -
ValueRay Target Price 318.7 12.8%